Donate by Dec. 31 for a 2025 tax receipt.
left to show your support and receive your 2025 tax receipt. Donate now.
At Sinai Health, urgent needs arise every day - whether it’s replacing life-saving surgical equipment, getting much-needed supplies or funding repairs to equipment used in breakthrough research. Emergencies don’t wait. Your gift today ensures we can act immediately when the unexpected happens.
Donors help fuel innovation and research at the Lunenfeld-Tanenbaum Research Institute (LTRI), one of the top 10 biomedical research facilities in the world. Your support expands access to state-of-the-art facilities, platforms and core services that are critical for discovering new and better treatments.
Supported by donor-funded platforms, Dr. Daniel Drucker discovered GLP-1, the hormone behind Ozempic that is transforming diabetes and obesity treatments.
Dr. Pamela Goodwin is a globally recognized medical oncologist and researcher whose groundbreaking work has transformed our understanding and treatment of breast cancer. With your support, she has led studies on therapies that improve survival and enhance quality of life for people living with cancer. Dr. Goodwin’s work firmly establishes her as a leader in advancing cancer care and improving patient outcomes.
In 2025, Dr. Goodwin was elected as a Fellow of the Royal Society of Canada (RSC) in recognition of her trailblazing research that has reshaped how breast cancer is understood and treated.
Our Level 3 Neonatal Intensive Care Unit (NICU) is one of Canada’s largest and busiest, providing the highest level of specialized care for more than 1,000 critically ill newborns each year. We’re one of the few NICUs in Ontario equipped to care for the most premature and medically fragile infants. With the ongoing commitment of our community and donors, we continue to advance innovation in neonatal medicine and give every newborn the strongest possible start in life.
In 2025, Dr. Goodwin was elected as a Fellow of the Royal Society of Canada (RSC) in recognition of her trailblazing research that has reshaped how breast cancer is understood and treated.
